MedPath

SepsisFLAGS ( FLuidAndGender)

Conditions
Sepsis
Registration Number
NCT03811483
Lead Sponsor
Karolinska Institutet
Brief Summary

In this single-center study the investigators will analyze gender differences among patients with suspected sepsis admitted to the Emergency Department at Södersjukhuset during a period of two years. About 11 000 patients will be included. Patient data including fluid therapy will be drawn from the electronic medical record; Take Care and Clinisoft. In the logistic regression analysis, the investigators will adjust for age, gender, comorbidities, vital signs, preliminary focus of infection, level of care and renal replacement therapy. The aim is to analyze gender differences in fluid treatment and the response to fluid treatment and if the treatment is associated with differences in mortality.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • Patients admitted to the emergency department with suspected sepsis (defined by blood culture taken and intravenous sepsis-antibiotics prescribed within 48 hours) and fulfilling sepsis-3 definition of sepsis (sequential organ failure assesment score of 2 or more)
Read More
Exclusion Criteria
  • Patients transferred from other hospitals or treatment clinics.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gender differences in fluid treatmentFluid therapy during the first six hours (adherence to sepsis bundles) and the first five days after admission.

Millilitres of fluid given per kilogram of patient weight (ml/kg).

Secondary Outcome Measures
NameTimeMethod
Type of fluidsFirst five days after admission.

Type according to Anatomical, Therapeutic and Chemical Classification System

Association between fluid therapy and need for/ dose of vasopressors/inotropic drugsFirst five days efter admission

Analyze the whole cohort and female/ male gender as subgroups

Association between fluid therapy and levels of lactatFirst five days efter admission

Analyze the whole cohort and female/ male gender as subgroups

Association between amount of fluid and mortalityIn-Hospital Mortality, 30- and 90-days mortality

Analyze the whole cohort and female/ male gender as subgroups

Trial Locations

Locations (1)

Södersjukhuset

🇸🇪

Stockholm, Stockholms Län, Sweden

© Copyright 2025. All Rights Reserved by MedPath